Compandia Announces Name Change

21-Sep-2010 - United Kingdom
Compandia has announced a name change to CompanDX. The company is a biomarker discovery company providing services to the Pharma and Biotech sectors but increasingly, as a result of in-house R&D, is identifying biomarkers that may lead to new diagnostic services and products of its own. Andy Sutton CEO of CompanDX explained: "We have grown the service side of the business over the last 9 months and are delivering biomarker discovery services to large pharma, small biotech and diagnostic companies. We and our investors have always recognised the significant upside potential in the research work we conduct with collaborators and in the laboratories of our founders, the new name reflects this activity as we start to build our IP portfolio around the signatures and biomarker panels we are developing."

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances